Canine degenerative myelopathy (DM) is a progressive, non-painful neurological disease affecting the spinal cord of older dogs. A genetic mutation in the SOD1 gene has been identified as a major risk factor. While there is no cure, understanding the disease trajectory and proactive welfare management can significantly improve quality of life throughout its course.
Genetics and Breed Predisposition
DM is associated with a homozygous SOD1 mutation — dogs with two copies of the at-risk allele are predisposed. The German Shepherd Dog, Corgi (Cardigan and Pembroke Welsh), Boxer, Chesapeake Bay Retriever, Bernese Mountain Dog, and several other breeds are overrepresented. Genetic testing is available, though not all homozygous dogs develop clinical disease — penetrance is incomplete and affected by age and possibly environmental factors.
Disease Progression
DM typically begins with loss of proprioception (awareness of limb position) and subtle weakness in the hind limbs, often asymmetric initially. Progression is relentless:
- Stage 1: Pelvic limb ataxia (wobbly gait), scuffing of paws
- Stage 2: Paraparesis — inability to support hindquarters, knuckling, and falling
- Stage 3: Paraplegia — complete hind limb paralysis; faecal and urinary incontinence
- Stage 4: Progression to forelimb involvement, dysphagia — rare as euthanasia is usually elected before this stage
Typical time from first signs to paraplegia is 6–36 months. DM is characteristically non-painful — distinguishing it from painful compressive spinal disease is important for management decisions.
Rehabilitation and Supportive Care
Physiotherapy and hydrotherapy: Evidence supports that intensive rehabilitation (underwater treadmill, land physiotherapy, massage) slows disease progression and maintains quality of life — some studies show meaningful extension of ambulation. Referral to a veterinary rehabilitation specialist is strongly recommended.
Mobility aids: Hindquarter wheelchairs allow paraplegic dogs to remain mobile and engaged with their environment. Dogs adapt remarkably well to wheelchairs and maintain excellent quality of life in Stages 2–3.
Nursing care: For paraplegic dogs — bladder expression or catheterisation, pressure sore prevention (frequent position changes, padded bedding), hygiene management for incontinent dogs.
Welfare Assessment and End-of-Life Decisions
Quality of life assessment in DM focuses on pain absence, maintained engagement and appetite, and owner capacity to provide the intensive nursing care required in advanced stages. Euthanasia should be considered when nursing requirements exceed owner capacity or when quality of life meaningfully declines. Because DM is non-painful, some dogs remain engaged and happy in paraplegia with excellent nursing — these dogs are not suffering and euthanasia should not be rushed solely on the basis of paralysis.